Reaction Details |
| Report a problem with these data |
Target | Cannabinoid receptor 2 |
---|
Ligand | BDBM50224069 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_450409 (CHEMBL900693) |
---|
Ki | 160±n/a nM |
---|
Citation | Stern, E; Muccioli, GG; Bosier, B; Hamtiaux, L; Millet, R; Poupaert, JH; Hénichart, JP; Depreux, P; Goossens, JF; Lambert, DM Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality. J Med Chem50:5471-84 (2007) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cannabinoid receptor 2 |
---|
Name: | Cannabinoid receptor 2 |
Synonyms: | CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2 |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 39690.94 |
Organism: | Homo sapiens (Human) |
Description: | P34972 |
Residue: | 360 |
Sequence: | MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILS
SHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTAS
VGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCS
ELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLD
VRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYA
LRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
|
|
|
BDBM50224069 |
---|
n/a |
---|
Name | BDBM50224069 |
Synonyms: | CHEMBL394230 | N3-(1-(3,5-dimethyl)adamantyl)-4-oxo-1-(3-phenylpropyl)-1,4-dihydroquinoline-3-carboxamide |
Type | Small organic molecule |
Emp. Form. | C31H36N2O2 |
Mol. Mass. | 468.6297 |
SMILES | CC12CC3CC(C)(C1)CC(C3)(C2)NC(=O)c1cn(CCCc2ccccc2)c2ccccc2c1=O |w:3.2,9.14,1.0,5.5,THB:8:5:2:10.9.11,8:9:4.5.7:2,11:9:4:7.1.2,11:1:4:10.8.9,TEB:12:9:4:7.1.2,12:9:4.5.7:2,0:1:4:10.8.9,0:1:10:4.5.8,6:5:2:10.9.11,6:5:10:1.2.11| |
Structure |
|